Showing results (411-420 of 470) with videos related to
Sort By:
Pageof 47
The New England Journal of Medicine|August 22, 2003
Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemiaBob Löwenberg, Wim van Putten, Matthias Theobald, et al.Blood|June 7, 2022
The genetic landscape of germline DDX41 variants predisposing to myeloid neoplasmsPeng Li, Sara Brown, Margaret Williams, et al.Journal of Immunology Research|January 19, 2017
Potential Involvement of Type I Interferon Signaling in Immunotherapy in Seasonal Allergic RhinitisLina Mattson, Antonio Lentini, Danuta R Gawel, et al.Leukemia|May 16, 2020
Dasatinib overcomes stroma-based resistance to the FLT3 inhibitor quizartinib using multiple mechanismsAmi B Patel, Anthony D Pomicter, Dongqing Yan, et al.Journal for Immunotherapy of Cancer|December 2, 2014
Detailed characterization of tumor infiltrating lymphocytes in two distinct human solid malignancies show phenotypic similaritiesMagdalena Kovacsovics-Bankowski, Lana Chisholm, Jonna Vercellini, et al.Zebrafish|February 10, 2016
Fish from Head to Tail: The 9th European Zebrafish Meeting in OsloGareth Griffiths, Ferenc Müller, Johan Ledin, et al.The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Dose-finding study of valspodar (PSC 833) with daunorubicin and cytarabine to reverse multidrug resistance in elderly patients with previously untreated acute myeloid leukemiaP Sonneveld, A Burnett, P Vossebeld, et al.Human Pathology|June 5, 2012
Multiplex high-throughput gene mutation analysis in acute myeloid leukemiaJennifer Dunlap, Carol Beadling, Andrea Warrick, et al.Stem Cell Reviews and Reports|September 20, 2015
One Standardized Differentiation Procedure Robustly Generates Homogenous Hepatocyte Cultures Displaying Metabolic Diversity from a Large Panel of Human Pluripotent Stem CellsAnnika Asplund, Arvind Pradip, Mariska van Giezen, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2014
Nonmyeloablative allogeneic hematopoietic stem cell transplant for the treatment of patients with hematologic malignancies using busulfan, fludarabine, and total body irradiation conditioning is effective in an elderly and infirm populationJonathan E Brammer, Alexander Stentz, James Gajewski, et al.Pageof 47